U.S. BioDefense, Inc. Launches Biotechnology And Defense Search Engine Development

CITY OF INDUSTRY, Calif., June 20 /PRNewswire-FirstCall/ -- U.S. BioDefense, Inc. announces that it has initiated development of a proprietary search engine focused on the Homeland Security, Defense and Biotechnology industries.

U.S. BioDefense's search engine will focus on providing critical search capabilities to both the general public and also to companies and government agencies to conduct research for coordinating resources and communications in preparation for and during emergencies. The crises management capabilities of the search engine can be useful in advance preparation and planning for any situation by taking advantage of the refined industry specific search results that filter the useful and information rich resources from the vast amounts of data on the Internet. The search engine will allow for socially constructed weighted results, meaning that the search engine will learn what resources are more informative and useful by direct user input and through proprietary software user analysis.

"The market once again is recognizing the value of Internet technology and more particularly the utility of search engines as witnessed by the recent success of the health care industry's Healthline, which recently raised $14 million, and Krugle, a software development industry search engine, which raised $6.1 million in investment capital," stated U.S. BioDefense CEO, David Chin. "The ad revenue that can be generated by delivering a highly targeted specific audience is significant and has already been well documented by the success of Google and Yahoo and has forced a shift in the marketing campaigns of all companies. Industry analysts expect online advertising expenditures to grow into a $20 billion industry."

About U.S. BioDefense, Inc.

U.S. BioDefense is a Department of Defense central contractor that researches, develops, and commercializes leading-edge biotechnology. U.S. BioDefense, Inc. is focused on transferring, researching, and commercializing groundbreaking technology from Universities, Research Labs, Fortune 500 Companies, and Government Agencies.

Safe Harbor Statement Forward-Looking Statements

Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the U.S. BioDefense's financial performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements. In addition, actual future results may differ materially from those anticipated, depending on a variety of factors, including continued maintenance of favorable license arrangements, success of market research identifying new product opportunities, successful introduction of new products, continued product innovation, the success of enhancements to the U.S. BioDefense's brand image, sales and earnings growth, ability to attract and retain key personnel, and general economic conditions affecting consumer spending, including uncertainties relating to global political conditions, such as terrorism. Information with respect to important factors that should be considered is contained in the U.S. BioDefense's Annual Report on Form 10-K as filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The U.S. BioDefense does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact: U.S. BioDefense, Inc. David Chin (626) 961-0562 info@usbiodefense.com

CONTACT: David Chin of U.S. BioDefense, Inc., +1-626-961-0562,info@usbiodefense.com